Previous Article | Next Article 
Journal of Virology, November 2001, p. 10663-10669, Vol. 75, No. 22
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.22.10663-10669.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Recruitment Times, Proliferation, and Apoptosis
Rates during the CD8+ T-Cell Response to Lymphocytic
Choriomeningitis Virus
Rob J.
De
Boer,1,*
Mihaela
Oprea,2
Rustom
Antia,3
Kaja
Murali-Krishna,4
Rafi
Ahmed,4 and
Alan S.
Perelson2
Theoretical Biology, Utrecht University, 3584 CH Utrecht, The Netherlands1;
Theoretical Division, Los Alamos National Laboratory, Los
Alamos, New Mexico 875452; and
Department of Biology3 and Emory
Vaccine Center and Department of Microbiology and
Immunology,4 Emory University, Atlanta, Georgia
30322
Received 15 March 2001/Accepted 11 August 2001
 |
ABSTRACT |
The specific CD8+ T-cell response during acute
lymphocytic choriomeningitis virus (LCMV) infection of mice is
characterized by a rapid proliferation phase, followed by a rapid death
phase and long-term memory. In BALB/c mice the immunodominant and
subdominant CD8+ responses are directed against the NP118
and GP283 epitopes. These responses differ mainly in the magnitude of
the epitope-specific CD8+ T-cell expansion. Using
mathematical models together with a nonlinear parameter estimation
procedure, we estimate the parameters describing the rates of change
during the three phases and thereby establish the differences between
the responses to the two epitopes. We find that CD8+ cell
proliferation begins 1 to 2 days after infection and occurs at an
average rate of 3 day
1, reaching the maximum population
size between days 5 and 6 after immunization. The 10-fold difference in
expansion to the NP118 and GP283 epitopes can be accounted for in our
model by a 3.5-fold difference in the antigen concentration of these
epitopes at which T-cell stimulation is half-maximal. As a consequence
of this 3.5-fold difference in the epitope concentration needed for
T-cell stimulation, the rates of activation and proliferation of T
cells specific for the two epitopes differ during the response and in
combination can account for the large difference in the magnitude of
the response. After the peak, during the death phase, the population
declines at a rate of 0.5 day
1, i.e., cells have an
average life time of 2 days. The model accounts for a memory cell
population of 5% of the peak population size by a reversal to memory
of 1 to 2% of the activated cells per day during the death phase.
 |
INTRODUCTION |
Acute viral infections are often
characterized by a rapid and extensive response of antigen-specific
CD8+ T cells (5, 8, 14, 18, 31). A typical
time course of an acute antiviral CD8+ T-cell response
involves an extensive proliferation phase, during which the specific
CD8+ populations may expand three to five orders of
magnitude; an apoptosis or death phase, during which 95% of
antigen-specific cells die; and a long-term memory phase (2,
31). At the time of the peak of the response most of the
activated CD8+ T-cell population in the spleen are specific
for lymphocytic choriomeningitis virus (LCMV) (18). The
main mechanism responsible for the contraction of the antigen-specific
T-cell population is the programmed cell death (20) of
CD8+ T cells that were activated by the viral antigens
(1, 3, 30). Migration of antigen-specific cells from the
spleen into solid tissue (21) may also contribute to the
contraction. The population size during the memory phase remains
approximately constant and is typically 5% of the peak value
(18).
The immune response to a virus usually involves several epitopes. The
CD8+ T-cell responses to dominant and subdominant epitopes
of LCMV all go through the phases of proliferation, death, and
long-term memory (18). Although the magnitude of a
subdominant response remains considerably smaller than that of the
dominant response (18), it is not clear what determines
the relative magnitude of these responses. Competition does not seem to
play a major role, as removal of the dominant response hardly increases
the subdominant response (26, 29). Additionally, recent
data suggest that naive CD8+ T cells undergo considerable
clonal expansion after a single early exposure to antigen (13,
16, 27). Thus, cells would have to compete for antigen in a very
short and early time window before the clones have expanded.
Additionally, there does not appear to be much competition between
memory populations to dominant and subdominant epitopes, as these
coexist for more than a year following the acute infection
(18). This is consistent with the suggestion that memory
cells are maintained by survival signals other than the specific
antigen (4, 19, 24, 25). Competition for the same antigen
would result in competitive exclusion (9-11). Much less
is known, however, about the role of competition for antigen during the
acute phase of the immune response.
Earlier studies suggested that the major difference between the
responses to dominant and subdominant epitopes is the "recruitment time" (6, 18). By starting earlier, the response to a
dominant epitope would achieve larger expansion than subdominant
responses. Developing mathematical models and using nonlinear parameter
estimation, we characterize the major parameters of the
CD8+ LCMV response (e.g., the rates of proliferation,
apoptosis, and memory cell formation) and show that the responses to
dominant and subdominant epitopes need differ only marginally in these rates to account for the data.
 |
MATERIALS AND METHODS |
Six- to 8-week-old male and female BALB/c mice were purchased
from the Jackson Laboratories (Bar Harbor, Maine). Mice were infected
with 2 × 105 PFU of LCMV Armstrong intraperitoneally
and sacrificed at days 3, 5, 8, 12, 15, 40, and 45 (three mice per time
point). The Elispot assay described by Taguchi et al. (23)
was modified by Murali-Krishna et al. (18) to detect
NP118- or GP283-specific CD8+ T cells in the spleen of
LCMV-infected mice. The frequency of epitope-specific CD8+
T cells was based on the percentage of CD8+ T cells present
in the responding population. Using this assay, we could accurately
measure a minimum of 10 spots among 106 responder cells
(18).
For both epitopes, the (naive) precursor frequency at day zero was
estimated as 1/200,000 cells (Blattman et al., submitted for
publication). For each epitope, this yields a naive precursor population size of about 60 cells per spleen.
For the viral load, we use the data of Lau et al. (14).
Following its introduction into the peritoneal cavity, the virus has a
very rapid expansion phase, reaching its maximal titer in the spleen in
about 2 days. The viral concentration remains within one log of this
maximal value for another 4 days and then declines by several orders of
magnitude over the next 3 days (14) (see Fig. 3). The
basic dynamics of virus and CD8 cells following infection with LCMV
Armstrong have been replicated many times, and the overall results are
very robust. We therefore feel confident that these previous data
(14) are appropriate for the present study.
Parameter estimates were obtained using the DNLS1 subroutine from the
Common Los Alamos Software Library, which is based on the
Levenberg-Marquardt algorithm (15) for solving nonlinear least-squares problems. These parameters were used to calculate the
predicted T-cell population size, and 95% confidence intervals for the
inferred parameters were then determined using a bootstrap method
(12), where the residuals to the optimal fit were
resampled 500 times.
Basic model.
Although the populations responding to the
NP118 and GP283 epitopes are oligoclonal (22), we simplify
the situation and consider two "clones" of antigen-specific
CD8+ T cells. The cells of each clone are either naive
(N), activated (A), or memory (M)
(Fig. 1). Activated cells proliferate at
rate
, die by apoptosis at rate
, and revert to memory cells at
rate r. Memory cells become reactivated at rate a
and die at rate
M. For reasons of simplicity,
naive cells are assumed to become activated at the same maximum rate,
a, as memory cells.

View larger version (15K):
[in this window]
[in a new window]
|
FIG. 1.
Scheme of the basic model depicting the step function
f(t). In this model we assume that naive T cells
are all activated when proliferation starts at
Ton. In the second model the step function
f(t) is replaced by a continuous function, 0 < f(t) < 1, that smoothly follows the
changes in the viral load. Solid lines indicate processes that are
positively influenced by the activation function. Dashed lines are
processes inhibited by antigen.
|
|
Because the viral burden during the acute response to LCMV Armstrong
switches so rapidly between very high and very low (14), we first approximate the antigenic stimulation of the CD8+
T cells by a function, f(t), that takes on only
two values; 0 when there is no activation, and 1 when there is full
activation. Assuming that antigenic stimulation switches "on" at
time Ton and "off" at time
Toff, we use for the activation function
f
|
(1)
|
The parameters Ton and
Toff are the times between which the virus
concentration is considered to be large enough to allow maximal T-cell
proliferation. The parameter Ton will be
referred to as the recruitment time. In this model, which we call the
on-off or basic model, we ignore the naive subpopulation and assume
that between time 0 and time Ton, all
antigen-specific naive CD8+ T cells become activated.
Later, we relax some of the simplifying assumptions of this model and
develop a model with a continuous activation function, which includes
naive T cells and follows the kinetics of their activation.
In this basic on-off model, the dynamics of the CD8+ T-cell
response is given by the following differential equations:
|
(2)
|
and
|
(3)
|
We assume that at the start of the response, i.e., time zero,
there are no memory cells, i.e., M(0) = 0, and that at
time Ton the number of activated cells
A has a value equal to the naive cell antigen-specific
precursor frequency. During a vigorous LCMV Armstrong infection, one
indeed observes that almost all precursor cells become activated
(13). When the activation function is on,
f(t) = 1, activated cells proliferate at
rate
, and any existing memory cells can become reactivated at rate
a. When the activation function is off,
f(t) = 0, activated cells die by apoptosis
at rate
and revert to memory cells at rate r. The
fraction r/(r +
) gives the fraction of
activated cells that successfully relax to memory cells.
The model is piecewise linear, and its explicit solutions are derived
in the Appendix.
 |
RESULTS |
Basic model.
The measured population sizes of the LCMV epitope
NP118- and GP283-specific CD8+ T cells in the spleen, as
assessed by a gamma interferon (IFN-
) Elispot assay between days 3 and 45, are depicted in Fig. 2. Each symbol in the figure represents one BALB/c mouse. The data point at day
zero reflects the initial precursor frequency, as assessed by Blattman
et al. (submitted). The solution of the model was fitted to these data
by a nonlinear multiparameter estimation procedure that minimized the
sum of squared residuals (SSR) between the data and the total number of
antigen-specific CD8+ T cells,
M(t) + A(t), predicted
by the model.

View larger version (15K):
[in this window]
[in a new window]
|
FIG. 2.
Fitting the on-off model to the data on the
CD8+ T-cell response to the NP118 epitope (A) and to the
GP283 epitope (B). For each epitope, the dashed lines depict the total
population size in the spleen, solid lines show activated cells, and
long-dashed lines show memory cells. The circle symbols represent the
experimental data.
|
|
Because in the basic model the responses to the two epitopes are not
coupled, the parameters can be estimated for each epitope independently. The results in Fig. 2A and B and in Table
1 indicate that the CD8+ T
cells specific for the two LCMV epitopes have small differences in
several parameters. The response to the dominant epitope starts somewhat earlier, the cells proliferate somewhat faster, and the proliferation phase ends somewhat later. NP118-specific cells also have
a somewhat higher apoptosis rate. The differences in the parameters for
the two epitopes are small, and the 95% confidence intervals overlap.
As indicated in Table 1, the estimated proliferation rate in the
NP118-specific response is about
= 3 day
1.
Proliferation starts around day 1.2 and stops around day 5.8. Having
4.6 days of proliferation at a rate of 2.9 day
1, one
expects a 6.2 × 106-fold expansion. The estimated
cellular death rate due to apoptosis is
= 0.5 day
1, yielding an average lifetime of activated cells
during the death phase of about 2 days. The rate at which activated
cells revert to the memory stage during the death phase is
r = 0.01 day
1. Because
r/(r +
)
0.02, the model
suggests that after Toff, 2% of the cells
leaving the activated pool revert to memory. Thus, memory cells
accumulate gradually, generating a total population comprising
approximately 5% of the peak population size (18). Note
that the 95% confidence limits on the reversal parameter are
relatively large. According to our estimates, the cells responding to
the subdominant GP283 epitope proliferate at a rate of 2.6 day
1 over 3.9 days, allowing a 2.5 × 104-fold expansion (Table 1). Thus, the combination of
small differences in various parameters markedy affects the magnitude
of the response (17). Because we ignore death during the
expansion phase (see equation A1 in the Appendix), the proliferation
rates that we estimate are net proliferation rates. If proliferating
cells also die, the true proliferation rate would be correspondingly higher.
Previous publications have suggested that the main difference between
dominant and subdominant responses is the recruitment time (6, 7,
18). To test this hypothesis, the two data sets were fitted
simultaneously, assuming that only the recruitment time
Ton differs between the two responses (Table
2). The values of the common parameters
ended up intermediate to those in Table 1. The required difference in
the recruitment time needed to best fit the data was about 20 h.
Visually, the fit appeared to be as good as that in Fig. 2 (not shown),
with the sum of the squared residuals differing marginally between the
two cases (8.1 versus 6.6). The total expansion for each epitope also
remains very similar. To test the hypothesis further, we also fitted
the opposite scenario by forcing Ton and
Toff to be the same for the dominant and
subdominant responses while allowing the other parameters to be
different (Table 3). Visually this fit is
also as good as that in Fig. 2. The sum of the squared residuals
(SSR = 7.3) is somewhat better than that obtained when only the
recruitment time Ton differs. The main
difference between the two responses in Table 3 is a 20% lower
proliferation rate of the subdominant response.
View this table:
[in this window]
[in a new window]
|
TABLE 2.
Parameter estimates for the response to the NP118 and the
GP283 epitopes fitted simultaneously by allowing only the
recruitment time to differa
|
|
View this table:
[in this window]
[in a new window]
|
TABLE 3.
Parameter estimates for the response to the NP118 and the
GP283 epitopes fitted simultaneously while forcing the recruitment
times Ton and Toff to
remain identicala
|
|
In summary, fitting the data on two epitopes separately and allowing
essentially all parameters to vary, the model accounts for the data by
small differences in various parameters. However, one cannot exclude a
single large difference in the recruitment time. The previous claims
were based on finding similar estimates for the proliferation rates of
the different responses (6, 7, 18). Since these estimates
were made rather crudely, one would not have been able to observe the
small (10%), but apparently important difference in the proliferation
rate found in Table 1 or the 20% difference required in Table 3.
Continuous model.
In reality, activation of a T-cell
population is not all or none, and the relatively weak GP283 response
may be due to a lower degree of antigenic stimulation. For example, the
NP118 and GP283 epitopes may differ in the way they get presented to T
cells and may trigger T-cell clones having different affinities for the resulting major histocompatibility complex (MHC)-peptide complexes. In
order to model different degrees of antigen stimulation of the T-cell
clones responding to the different epitopes, we let T-cell activation
depend on a saturation function of the viral load, V,
|
(4)
|
Here the parameter K determines the amount of antigen
needed to generate half-maximal stimulation. Thus, a clone
characterized by a low value of K would be easier to
stimulate with a given amount of virus than a clone characterized by a
large value of K. Both the viral load and the K
parameter are measured in PFU per spleen (14).
We do not explicitly model the viral load, but rather assume that the
viral load, V, changes with time according to the curve given in Lau et al. (14) and shown in Fig.
3A. Assuming exponential dynamics, we
interpolated the data in Lau et al. (14) between the
available points (see Fig. 3A). We model the different sensitivity of
the two T-cell clones to their specific epitopes by different stimulation parameters K.

View larger version (17K):
[in this window]
[in a new window]
|
FIG. 3.
Dynamics of the NP118- and GP283-specific cell
populations in the continuous model. (A) Broken line gives the viral
load in PFU per spleen (14), the heavy line gives the
total population size of the NP118 response, and the light line gives
that of the GP283 response. (B) Subpopulations within each clone. Solid
lines depict activated cells, long-dashed lines show memory cells, and
short-dashed lines show naive cells (14).
|
|
The model now becomes
|
(5)
|
|
(6)
|
|
(7)
|
This model depends on the virus loads reported by Lau et al.
(14), and through the function F(V),
the viral load determines the actual rates of activation,
proliferation, memory formation, and apoptosis. For example, the rate
of proliferation of an activated cell is now
F(V) and hence varies during the response,
with
being the maximum rate and
F(V) being a factor that varies between 0 and 1. In modeling the response to the NP118 and GP283 epitopes, we examine
the case in which the two epitopes differ in antigen availability only,
i.e., the K parameter only, and the maximum rates of T-cell
activation, proliferation, memory formation, and apoptosis are equal
for both epitopes.
This model was fitted to the data for both epitopes simultaneously. We
first found fits to the data with low activation rates a and
unrealistically high proliferation rates
. As a
consequence, there was hardly any depletion of the naive precursor
population by activation. Because we think most specific precursors
become activated during the immune response, we fixed the activation rate at a = 1 day
1. Naive precursors thus
become activated and depleted on a time scale of days
(28) (Fig. 3B and Table 4).
View this table:
[in this window]
[in a new window]
|
TABLE 4.
Parameter estimates for the NP118 and GP283 epitopes
obtained by simultaneously fitting the data for both epitopes in
the continuous modela
|
|
The fit to the data is similar in quality to that of the on-off model.
This shows that the parameter differences between the NP118 and the
GP283 response can indeed be accounted for by a difference in the
K parameter. By our parameter estimates, the GP283 CD8
response requires a 3.5-fold-higher antigen concentration to achieve a
similar degree of stimulation as the NP118 response. We also consider a
worst-case scenario by assuming that the activation function is the
same for the different biological processes in the model, i.e.,
activation, proliferation, and apoptosis are all governed by the same
K parameter. Our model with a single K parameter
is a special case of a model allowing for different values of the
K parameter. Because we can fit the data with a single
K, it is clear that we could also fit the data to a model having several K parameters; however, we would have little
confidence in the various K values.
Figure 4 depicts the actual activation,
proliferation, and apoptosis rates over time. Note that in the
continuous model, proliferation, for example, occurs at rate
F(V) per cell. Consistent with the results of
the on-off model, we find small differences in the actual values of
several rates. The largest difference seems to be that the actual
proliferation rate declines more slowly in response to the dominant
epitope. This extends the proliferation period and allows a larger
clonal expansion.

View larger version (20K):
[in this window]
[in a new window]
|
FIG. 4.
Actual activation rates
F(V)a (solid lines), proliferation
rates F(V) (long-dashed lines), and apoptosis
rates F(V) (short-dashed lines). Heavy lines
give the NP118 response, and light lines give the GP283 response.
|
|
As shown in Fig. 4, the time courses for the activation rates are very
similar for both epitopes. Thus, there is little difference in the
recruitment rate of naive CD8+ T cells specific for the two
epitopes. Since our activation function depends only on the viral load
and not on the time of the response, the model suffers from the
artifact that the apoptosis rate is high early in the response when the
viral load is still low (Fig. 4). This is probably not realistic but
hardly affects the behavior of the model because there are very few
activated cells present at this early state of the response (Fig. 3).
Summarizing, the data are most parsimoniously explained by a 3.5-fold
difference in the parameters K, i.e., by a difference in the
antigen concentration required for half-maximal stimulation.
 |
DISCUSSION |
We have developed two simple models for the CD8+
T-cell response to LCMV in mice. In one of the models, we assumed that
T-cell activation is an all-or-none process, while in a more complex model we allowed a continuous change in activation level. Using these
models, we have shown that the immune responses to the dominant NP118
epitope and the subdominant GP283 epitope in the LCMV CD8+
T-cell immune response may involve differences in the proliferation period and the actual proliferation rates. The most parsimonious explanation for these differences is a difference in the antigenic stimulation of the two responses. In our model the subdominant response
requires a 3.5-fold-higher antigen load than the dominant response to
achieve similar stimulation. This small difference in the antigen
stimulation allows a slightly earlier recruitment and a somewhat higher
proliferation rate over a somewhat longer time period in response to
the dominant NP118 epitope (Fig. 4). In both models, we found that the
large difference in the magnitude of the response to the two epitopes
can be accounted for by small differences in various parameters
(17).
Previous papers addressing the differences between dominant and
subdominant responses confirm that immune responses to different epitopes on the same pathogen expand, contract, and enter the memory
T-cell compartment synchronously (6, 7). These studies have argued, however, that the main difference in the dynamics between
the responses to different epitopes of the same antigen is the timing
of recruitment (6, 7, 18). This argument was based largely
on the observation that the proliferation rates seemed relatively
similar. Since previously the proliferation rates were measured rather
crudely, the evidence arguing that only the recruitment times differ
was relatively weak. Our more accurate calculations demonstrate that
accounting for the large difference in the magnitude of the two
responses by this argument requires a 20-h difference in the
recruitment time (Table 2). Although such a large difference in the
recruitment time cannot be excluded at present, we show that small
differences in the various parameters affecting the proliferation rate
over time also account for the large difference between the NP118 and
GP283 responses.
The two models developed for the parameter estimation are relatively
simple and only allow us to estimate a proliferation rate during the
expansion phase and death and reversal rates during the contraction
phase. Thanks to this simplicity, we expect that our parameter
estimates are fairly general. Indeed, we have experimented with several
versions of the models and found similar results (not shown). Despite
the simplicity of the models, we have shown that alternative parameter
fittings remain possible. The on-off model can account for the data by
a difference in the recruitment time or in the proliferation rate only
and in the continuous model we had to fix the activation rate to ensure
a sufficient activation of the precursor cells.
In animals primed with the GP283 epitope, the response to the this
subdominant epitope dominates over the otherwise dominant response to
the NP118 epitope (Ahmed et al., unpublished data). This is in good
agreement with the small difference in the estimated parameters
reported here. Starting with a large population of GP283-specific
CD8+ memory T cells, the somewhat faster NP118-specific
response is not expected to overtake the GP283 population before the
GP283-specific cytotoxic T lymphocytes could eliminate the antigen.
Recent data demonstrate that CD8+ T cells undergo
considerable clonal expansion after an initial exposure to antigen
(13, 16, 27). A relatively short stimulus by antigen,
i.e., less than 2 h (27), "programs" CD8+
T cells to divide several times in an antigen-independent manner. Note
that in Fig. 3 proliferation indeed continues after the virus has been
cleared. While the details of antigen-independent proliferation are not
known at present, this could imply that our simple on-off model is more
realistic than the more complicated continuous model, in which the
proliferation rate depends on the antigen concentration. The off switch
in the on-off model is an independent parameter that could also reflect
the end of the programmed cell division cascade. Thus, the on-off model
allows us to estimate the rate constants for the responses to the two
epitopes during the various phases of the response and suggests that
small differences in the growth rate and/or the recruitment time can
account for the phenomenon of immunodominance.
Summarizing, we have presented a model that accounts for the kinetics
of the dominant and sub dominant CD8+ T-cell immune
responses to LCMV infection. Fitting data to the model, we estimate a
proliferation rate of 3 day
1 in the dominant response.
During the apoptotic death phase, activated cells have an average life
span of 2 days, and on a daily basis 1 to 2% of the activated cells
revert to the memory stage. By the accumulation of memory cells, the
memory population is about 5% of the population size at the peak of
the response by the end of the death phase.
 |
APPENDIX |
The model defined by equations 1 to 3 is piecewise linear. When
t < Ton, there is no antigenic
stimulation, and M(t) = 0. Naive cells
become activated during this time interval, according to an unspecified
dynamics, so that at Ton, all naive precursors have become activated cells. For Ton
t < Toff, i.e.,
f(t) = 1, memory cells are still absent and
activated cells expand exponentially at a rate
, so that
the solution obeys
|
(A1)
|
Following the peak, i.e., for t
Toff, f(t) = 0 and
hence the cell populations obey the following linear model:
|
(A2)
|
|
(A3)
|
with solution
|
(A4)
|
|
(A5)
|
where A(Toff) = A(0) exp[
(Toff
Ton)].
 |
ACKNOWLEDGMENTS |
The first two authors contributed equally to this work.
Portions of the work were done under the auspices of the U.S.
Department of Energy. A.S.P. is supported by NIH grant AI28433 and the
Joseph P. Sullivan and Jeanne M. Sullivan Foundation.
 |
FOOTNOTES |
*
Corresponding author. Mailing address. Theoretical
Biology, Utrecht University, Padualaan 8, 3584 CH Utrecht, The
Netherlands. Phone: 31 30 253 7650. Fax: 31 30 251 3655. E-mail:
R.J.DeBoer{at}bio.uu.nl.
 |
REFERENCES |
| 1.
|
Abbas, A. K.
1996.
Die and let live: eliminating dangerous lymphocytes.
Cell
84:655-657[CrossRef][Medline].
|
| 2.
|
Ahmed, R., and D. Gray.
1996.
Immunological memory and protective immunity: understanding their relation.
Science
272:54-60[Abstract].
|
| 3.
|
Akbar, A. N., and M. Salmon.
1997.
Cellular environments and apoptosis: tissue microenvironments control activated T-cell death.
Immunol. Today
18:72-76[CrossRef][Medline].
|
| 4.
|
Antia, R.,
S. S. Pilyugin, and R. Ahmed.
1998.
Models of immune memory: on the role of cross-reactive stimulation, competition, and homeostasis in maintaining immune memory.
Proc. Natl. Acad. Sci. USA.
95:14926-14931[Abstract/Free Full Text].
|
| 5.
|
Asano, M. S., and R. Ahmed.
1996.
CD8 T cell memory in B cell-deficient mice.
J. Exp. Med.
183:2165-2174[Abstract/Free Full Text].
|
| 6.
|
Bousso, P.,
J. P. Levraud,
P. Kourilsky, and J. P. Abastado.
1999.
The composition of a primary T cell response is largely determined by the timing of recruitment of individual T cell clones.
J. Exp. Med.
189:1591-1600[Abstract/Free Full Text].
|
| 7.
|
Busch, D. H.,
I. M. Pilip,
S. Vijh, and E. G. Pamer.
1998.
Coordinate regulation of complex T cell populations responding to bacterial infection.
Immunity
8:353-362[CrossRef][Medline].
|
| 8.
|
Butz, E. A., and M. J. Bevan.
1998.
Massive expansion of antigen-specific CD8+ T cells during an acute virus infection.
Immunity
8:167-175[CrossRef][Medline].
|
| 9.
|
De Boer, R. J., and A. S. Perelson.
1994.
T cell repertoires and competitive exclusion.
J. Theor. Biol.
169:375-390[CrossRef][Medline].
|
| 10.
|
De Boer, R. J., and A. S. Perelson.
1995.
Towards a general function describing T cell proliferation.
J. Theor. Biol.
175:567-576[CrossRef][Medline].
|
| 11.
|
De Boer, R. J., and A. S. Perelson.
1997.
Competitive control of the self-renewing T cell repertoire.
Int. Immunol.
9:779-790[Abstract/Free Full Text].
|
| 12.
|
Efron, B., and R. Tibshirani.
1986.
Bootstrap methods for standard errors, confidence intervals, and other measures of statistical accuracy.
Stat. Sci.
1:54-77.
|
| 13.
|
Kaech, S. M., and R. Ahmed.
2001.
Memory CD8+ T cell differentiation: initial antigen encounter triggers a developmental program in naive cells.
Nat. Immunol.
2:415-422[Medline].
|
| 14.
|
Lau, L. L.,
B. D. Jamieson,
T. Somasundaram, and R. Ahmed.
1994.
Cytotoxic T-cell memory without antigen.
Nature
369:648-652[CrossRef][Medline].
|
| 15.
|
Marquardt, D. W.
1963.
Finite difference algorithm for curve fitting.
J. Soc. Ind. Appl. Math.
11:431-441[CrossRef].
|
| 16.
|
Mercado, R.,
S. Vijh,
S. E. Allen,
K. Kerksiek,
I. M. Pilip, and E. G. Pamer.
2000.
Early programming of T cell populations responding to bacterial infection.
J. Immunol.
165:6833-6839[Abstract/Free Full Text].
|
| 17.
|
Müller, V.,
A. F. Marée, and R. J. De Boer.
2001.
Small variations in multiple parameters account for wide variations in HIV-1 set-points: a novel modelling approach.
Proc. R. Soc. Lond. B Biol. Sci.
268:235-242[Medline].
|
| 18.
|
Murali-Krishna, K.,
J. D. Altman,
M. Suresh,
D. J. Sourdive,
A. J. Zajac,
J. D. Miller,
J. Slansky, and R. Ahmed.
1998.
Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection.
Immunity
8:177-187[CrossRef][Medline].
|
| 19.
|
Murali-Krishna, K.,
L. L. Lau,
S. Sambhara,
F. Lemonnier,
J. Altman, and R. Ahmed.
1999.
Persistence of memory CD8 T cells in MHC class I-deficient mice.
Science
286:1377-1381[Abstract/Free Full Text].
|
| 20.
|
Raff, M. C.
1992.
Social controls on cell survival and cell death.
Nature
356:397-400[CrossRef][Medline].
|
| 21.
|
Reinhardt, R. L.,
A. Khoruts,
R. Merica,
T. Zell, and M. K. Jenkins.
2001.
Visualizing the generation of memory CD4 T cells in the whole body.
Nature
410:101-105[CrossRef][Medline].
|
| 22.
|
Sourdive, D. J.,
K. Murali-Krishna,
J. D. Altman,
A. J. Zajac,
J. K. Whitmire,
C. Pannetier,
P. Kourilsky,
B. Evavold,
A. Sette, and R. Ahmed.
1998.
Conserved T cell receptor repertoire in primary and memory CD8 T cell responses to an acute viral infection.
J. Exp. Med.
188:71-82[Abstract/Free Full Text].
|
| 23.
|
Taguchi, T.,
J. R. McGhee,
R. L. Coffman,
K. W. Beagley,
J. H. Eldridge,
K. Takatsu, and H. Kiyono.
1990.
Detection of individual mouse splenic T cells producing IFN-gamma and IL-5 using the enzyme-linked immunospot (ELISPOT) assay.
J. Immunol. Methods
128:65-73[CrossRef][Medline].
|
| 24.
|
Tanchot, C.,
F. A. Lemonnier,
B. Perarnau,
A. A. Freitas, and B. Rocha.
1997.
Differential requirements for survival and proliferation of CD8 naive or memory T cells.
Science
276:2057-2062[Abstract/Free Full Text].
|
| 25.
|
Tanchot, C., and B. Rocha.
1998.
The organization of mature T-cell pools.
Immunol. Today
19:575-579[CrossRef][Medline].
|
| 26.
|
Van der Most, R. G.,
A. Sette,
C. Oseroff,
J. Alexander,
K. Murali-Krishna,
L. L. Lau,
S. Southwood,
J. Sidney,
R. W. Chesnut,
M. Matloubian, and R. Ahmed.
1996.
Analysis of cytotoxic T cell responses to dominant and subdominant epitopes during acute and chronic lymphocytic choriomeningitis virus infection.
J. Immunol.
157:5543-5554[Abstract].
|
| 27.
|
Van Stipdonk, M. J.,
E. E. Lemmens, and S. P. Schoenberger.
2001.
Naive CTLs require a single brief period of antigenic stimulation for clonal expansion and differentiation.
Nat. Immunol.
2:423-429[Medline].
|
| 28.
|
Veiga-Fernandes, H.,
U. Walter,
C. Bourgeois,
A. McLean, and B. Rocha.
2000.
Response of naive and memory CD8+ T cells to antigen stimulation in vivo.
Nat. Immunol.
1:47-53[CrossRef][Medline].
|
| 29.
|
Vijh, S.,
I. M. Pilip, and E. G. Pamer.
1999.
Noncompetitive expansion of cytotoxic T lymphocytes specific for different antigens during bacterial infection.
Infect. Immun.
67:1303-1309[Abstract/Free Full Text].
|
| 30.
|
Welsh, R. M.,
L. K. Selin, and E. S. Razvi.
1995.
Role of apoptosis in the regulation of virus-induced T cell responses, immune suppression, and memory.
J. Cell Biochem.
59:135-142[CrossRef][Medline].
|
| 31.
|
Zimmerman, C.,
K. Brduscha-Riem,
C. Blaser,
R. M. Zinkernagel, and H. Pircher.
1996.
Visualization, characterization, and turnover of CD8+ memory T cells in virus-infected hosts.
J. Exp. Med.
183:1367-1375[Abstract/Free Full Text].
|
Journal of Virology, November 2001, p. 10663-10669, Vol. 75, No. 22
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.22.10663-10669.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Handel, A., Antia, R.
(2008). A Simple Mathematical Model Helps To Explain the Immunodominance of CD8 T Cells in Influenza A Virus Infections. J. Virol.
82: 7768-7772
[Abstract]
[Full Text]
-
Ganusov, V. V.
(2007). Discriminating between Different Pathways of Memory CD8+ T Cell Differentiation. J. Immunol.
179: 5006-5013
[Abstract]
[Full Text]
-
Althaus, C. L., Ganusov, V. V., De Boer, R. J.
(2007). Dynamics of CD8+ T Cell Responses during Acute and Chronic Lymphocytic Choriomeningitis Virus Infection. J. Immunol.
179: 2944-2951
[Abstract]
[Full Text]
-
Regoes, R. R., Barber, D. L., Ahmed, R., Antia, R.
(2007). Estimation of the rate of killing by cytotoxic T lymphocytes in vivo. Proc. Natl. Acad. Sci. USA
104: 1599-1603
[Abstract]
[Full Text]
-
Maree, A. F. M., Santamaria, P., Edelstein-Keshet, L.
(2006). Modeling competition among autoreactive CD8+ T cells in autoimmune diabetes: implications for antigen-specific therapy. Int Immunol
18: 1067-1077
[Abstract]
[Full Text]
-
Gil, M. P., Salomon, R., Louten, J., Biron, C. A.
(2006). Modulation of STAT1 protein levels: a mechanism shaping CD8 T-cell responses in vivo. Blood
107: 987-993
[Abstract]
[Full Text]
-
Rouzine, I. M., Sergeev, R. A., Glushtsov, A. I.
(2006). Two types of cytotoxic lymphocyte regulation explain kinetics of immune response to human immunodeficiency virus. Proc. Natl. Acad. Sci. USA
103: 666-671
[Abstract]
[Full Text]
-
Bartholdy, C., Stryhn, A., Christensen, J. P., Thomsen, A. R.
(2004). Single-Epitope DNA Vaccination Prevents Exhaustion and Facilitates a Broad Antiviral CD8+ T Cell Response during Chronic Viral Infection. J. Immunol.
173: 6284-6293
[Abstract]
[Full Text]
-
Davenport, M. P., Ribeiro, R. M., Perelson, A. S.
(2004). Kinetics of Virus-Specific CD8+ T Cells and the Control of Human Immunodeficiency Virus Infection. J. Virol.
78: 10096-10103
[Abstract]
[Full Text]
-
Turner, S. J., La Gruta, N. L., Stambas, J., Diaz, G., Doherty, P. C.
(2004). Differential tumor necrosis factor receptor 2-mediated editing of virus-specific CD8+ effector T cells. Proc. Natl. Acad. Sci. USA
101: 3545-3550
[Abstract]
[Full Text]
-
Probst, H. C., Tschannen, K., Gallimore, A., Martinic, M., Basler, M., Dumrese, T., Jones, E., van den Broek, M. F.
(2003). Immunodominance of an Antiviral Cytotoxic T Cell Response Is Shaped by the Kinetics of Viral Protein Expression. J. Immunol.
171: 5415-5422
[Abstract]
[Full Text]
-
De Boer, R. J., Homann, D., Perelson, A. S.
(2003). Different Dynamics of CD4+ and CD8+ T Cell Responses During and After Acute Lymphocytic Choriomeningitis Virus Infection. J. Immunol.
171: 3928-3935
[Abstract]
[Full Text]
-
Hathcock, K. S., Kaech, S. M., Ahmed, R., Hodes, R. J.
(2003). Induction of Telomerase Activity and Maintenance of Telomere Length in Virus-Specific Effector and Memory CD8+ T Cells. J. Immunol.
170: 147-152
[Abstract]
[Full Text]
-
Pierson, T. C., Zhou, Y., Kieffer, T. L., Ruff, C. T., Buck, C., Siliciano, R. F.
(2002). Molecular Characterization of Preintegration Latency in Human Immunodeficiency Virus Type 1 Infection. J. Virol.
76: 8518-8531
[Abstract]
[Full Text]